Competitive Blockers
Moderate
Textbook
Enhanced neuromuscular blockade.
Source: KDT 7e · p347-359
Drug reference
lincomycin
Lincosamide antibiotic · Antibacterial
Lincosamide antibioticAntibacterialATC null
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
X
FDA category + note
Mechanism
null
Indications
largely replaced by clindamycin due to higher incidence of diarrhoea and colitis and less potency
Dosing
- Adult
- 500 mg TDS-QID oral; 600 mg i.m. or by i.v. infusion 6–12 hrly
Pharmacokinetics
Half-life
5 hrs
Excretion
excreted mainly in bile
Side effects
Common
diarrhoeacolitis
Pregnancy & lactation
Pregnancy
X
Drug interactions
11 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Related guidelines
Acute diarrhoea in children
IAP · Pediatrics · 2022
Acute dental pain and intraoral swelling
ADA_DENTAL · Dentistry · 2019
Infective endocarditis prevention
ADA_DENTAL · Dentistry · 2015
Gastric premalignant conditions
ACG · Gastroenterology · 2025
Preventive care in inflammatory bowel disease
ACG · Gastroenterology · 2025
Ask House about lincomycin
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team